Show simple item record

 
dc.contributorInstitut d'Assistència Sanitària
dc.contributor.authorLópez, Beatriz
dc.contributor.authorRaya I Casanova, Òscar
dc.contributor.authorBaykova, Evgenia
dc.contributor.authorSaez, Marc
dc.contributor.authorRigau, David
dc.contributor.authorCunill, Ruth
dc.contributor.authorMAYORAL MOYANO, SACRAMENTO
dc.contributor.authorCarrion, Carme
dc.contributor.authorSerrano, Domènec
dc.contributor.authorCastells, Xavier
dc.date.accessioned2023-05-15T09:13:02Z
dc.date.available2023-05-15T09:13:02Z
dc.date.issued2023-02
dc.identifier.citationLópez B, Raya O, Baykova E, Saez M, Rigau D, Cunill R, et al. APPRAISE-RS: Automated, updated, participatory, and personalized treatment recommender systems based on GRADE methodology. Heliyon. 2023 Feb;9(2):e13074.
dc.identifier.issn2405-8440
dc.identifier.urihttps://hdl.handle.net/11351/9531
dc.descriptionAttention deficit hyperactivity disorder; Evidence-based medicine; Meta-analysis
dc.description.abstractPurpose: Clinical practice guidelines (CPGs) have become fundamental tools for evidence-based medicine (EBM). However, CPG suffer from several limitations, including obsolescence, lack of applicability to many patients, and limited patient participation. This paper presents APPRAISE-RS, which is a methodology that we developed to overcome these limitations by automating, extending, and iterating the methodology that is most commonly used for building CPGs: the GRADE methodology.Method: APPRAISE-RS relies on updated information from clinical studies and adapts and automates the GRADE methodology to generate treatment recommendations. APPRAISE-RS provides personalized recommendations because they are based on the patient's individual characteristics. Moreover, both patients and clinicians express their personal preferences for treatment outcomes which are considered when making the recommendation (participatory). Rule-based system approaches are used to manage heuristic knowledge.Results: APPRAISE-RS has been implemented for attention deficit hyperactivity disorder (ADHD) and tested experimentally on 28 simulated patients. The resulting recommender system (APPRAISE-RS/TDApp) shows a higher degree of treatment personalization and patient participation than CPGs, while recommending the most frequent interventions in the largest body of evidence in the literature (EBM). Moreover, a comparison of the results with four blinded psychiatrist prescriptions supports the validation of the proposal.Conclusions: APPRAISE-RS is a valid methodology to build recommender systems that manage updated, personalized and participatory recommendations, which, in the case of ADHD includes at least one intervention that is identical or very similar to other drugs prescribed by psychiatrists.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesHeliyon;9(2)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectTrastorn per dèficit d'atenció amb hiperactivitat
dc.subjectMedicina basada en l'evidència
dc.subjectMetaanàlisi
dc.subject.meshAttention Deficit Disorder with Hyperactivity
dc.subject.meshEvidence-Based Medicine
dc.subject.meshMeta-Analysis
dc.titleAPPRAISE-RS: Automated, updated, participatory, and personalized treatment recommender systems based on GRADE methodology
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.heliyon.2023.e13074
dc.subject.decstrastornos de déficit de atención con hiperactividad
dc.subject.decsmedicina basada en datos científicos
dc.subject.decsmetaanálisis
dc.relation.publishversionhttps://doi.org/10.1016/j.heliyon.2023.e13074
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.event.productorBiblioteca
dc.contributor.authoraffiliation[López B, Raya O] Enginyeria de Control i Sistemes Intel·ligents (eXiT), Universitat de Girona, Spain. [Baykova E, Mayoral S, Serrano D] Institut d'Assistència Sanitària (ICS-IAS), Girona, Spain. [Saez M] Grup de Recerca en Estadística, Econometria i Salut, Universitat de Girona, Spain. Epidemiologia i Salut Pública (CIBERESP), Madrid, Spain. [Rigau D] Cochrane Iberoamerica, Barcelona, Spain. [Cunill R] Parc Sanitari de Sant Joan de Déu-Numància, Barcelona, Spain. [Castells X] Grup de Recerca TransLab, Departament de Ciències Mèdiques, Universitat de Girona, Spain
dc.identifier.pmid36798764
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record